Congratulations to our partners at Valitacell!
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announces it has acquired ValitaCell Ltd. (“ValitaCell”), the biotechnology company that creates pioneering analytical products and technologies for the biopharmaceutical industry.
The announcement was made today, September 13th, 2022.
“ValitaCell has a proven record for delivering innovative products and we are excited to build upon our successful partnership with Beckman Coulter Life Sciences,” said Dr Jerry Clifford, Co-Founder and CEO of ValitaCell. “We never take for granted what our advancements can do for patients while also reducing manual workflow burdens on laboratory staff. Together with Beckman Coulter Life Sciences, we will advance our shared ambition to accelerate and enable the sustainable manufacture of innovative biological medicines to bring them to market faster.”
Read the official press release here.